(Alliance News) - Syncona Ltd on Thursday said investee Achilles Therapeutics PLC has amended a US regulatory filing in relation to an offering of American depositary shares.
The document sent to the US Securities & Exchange Commission said Achilles ADS shares will be priced between USD17.00 and USD19.00 each. They each represent one ordinary share in the company.
Life sciences-focused investor Synonca said this would represent an increase of its holding in Achilles to between GBP42.9 million and GBP59.1 million.
Syncona shares were flat at 262.50 pence each in London on Thursday.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Syncona (SYNC)